Inhibition of CHI3L1 decreases N-cadherin and VCAM-1 levels in glioblastoma

Agnieszka Rusak1, Marlena Gąsior-Głogowska2, Azzurra Sargenti3

  • 1Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chalubinskiego St. 6a, 50-368 Wroclaw, Poland.

Research Square
|October 14, 2024
PubMed
Abstract

Insights

Chitinase-3-like protein 1 (CHI3L1) inhibition reduces glioblastoma multiforme (GBM) invasiveness. This study utilized 3D GBM spheroids to investigate CHI3L1

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Chitinase-3-like protein 1 (CHI3L1) promotes cancer progression via angiogenesis, invasion, and immunomodulation.
  • CHI3L1 is highly expressed in glioblastoma multiforme (GBM), a highly angiogenic cancer.
  • Targeting CHI3L1 offers potential for precision medicine in GBM treatment.

Purpose of the Study:

  • To investigate the effect of CHI3L1 inhibition on GBM invasiveness using a 3D spheroid model.
  • To analyze the interaction between CHI3L1 and the inhibitor G721-0282.
  • To assess changes in key molecular markers associated with GBM invasion.

Main Methods:

  • Molecular docking and infrared spectroscopy to analyze CHI3L1 and G721-0282 interaction.
  • Label-free physical cytometry to measure inhibitor uptake in GBM spheroids.
  • Immunohistochemistry, Western blot, and ddPCR to analyze cadherins, VCAM-1, and EGFR expression.

Main Results:

  • Direct interaction confirmed between CHI3L1 and G721-0282.
  • G721-0282 significantly decreased N-cadherins and VCAM-1 in 3D GBM spheroids.
  • Observed differential effects of G721-0282 on U-87 MG cells in 2D vs. 3D models.

Conclusions:

  • CHI3L1 inhibition demonstrates potential in reducing GBM tumor invasiveness.
  • The 3D GBM spheroid model is valuable for studying tumor microenvironment and membrane protein alterations.
  • Further research into CHI3L1 inhibition could lead to novel GBM therapies.